Figure 4.
Effect of the treatment with increasing concentrations of 6 and 7 over 3 days on viability of MV4-11 cells: (A) in the absence and presence of 2 (lenalidomide, 10 μM); (B) wild type vs CRBN–/– MV4-11 cells.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.